Lamisopt Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Dorzolamide

Indications/Uses

To lower raised pressure in the eye & treat glaucoma as monotherapy or in addition to other medicines which lower pressure in the eye eg, β-blockers.

Click to view Lamisopt detailed prescribing information

Dosage/Direction for Use

Monotherapy 1 drop in the affected eye(s) in the morning, afternoon & evening. Use w/ β-blocker eye drop 1 drop in the affected eye(s) in the morning & evening at least 10 min apart.

Click to view Lamisopt detailed prescribing information

Contraindications

Allergy. Severe kidney impairment, or prior history of kidney stones.

Click to view Lamisopt detailed prescribing information

Special Precautions

Discontinue if an allergic reaction is suspected. Patients with history of eye problems & surgeries, & any medication allergies. Patient may develop eye irritation or problems eg, redness of the eye or swelling of the eyelids. May discolour soft contact lenses. Remove contact lenses prior to application & wait at least 15 min before reinsertion. May affect ability to drive or operate machinery. Liver impairment. Not for use during pregnancy. Not recommended in lactation.

Click to view Lamisopt detailed prescribing information

Use In Pregnancy & Lactation

Click to view Lamisopt detailed prescribing information

Adverse Reactions

Burning & stinging of the eyes. Sore eye & blurred vision, discharge w/ itching of the eyes, irritation/inflammation of the eyelid, headache, nausea, bitter taste, & fatigue.

Drug Interactions

Carbonic anhydrase inhibitor eg, acetazolamide; sulfa drugs.

Click to view Lamisopt detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Lamisopt detailed prescribing information

Storage

View Lamisopt storage conditions for details to ensure optimal shelf-life.

Description

View Lamisopt description for details of the chemical structure and excipients (inactive components).

Action

View Lamisopt mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiglaucoma Preparations

ATC Classification

S01EC03 - dorzolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.

Regulatory Classification

POM

Presentation/Packing

Form

Lamisopt eye drops 20 mg/mL

Packing/Price

5 mL x 1's

Lamisopt

dorzolamide

Manufacturer:

Rafarm

Distributor:

Maxxcare

Marketer:

Mega Lifesciences